Viewing Study NCT04038502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-01-22 @ 12:07 PM
Study NCT ID: NCT04038502
Status: RECRUITING
Last Update Posted: 2025-08-20
First Post: 2019-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Sponsor: VA Office of Research and Development
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castrate Resistant Prostate Cancer View
None BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 View
None RAD51B, RAD51C, RAD51D, or RAD54L Mutations View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic prostate cancer View